Society for Immunotherapy of Cancer Annual Meeting 2026

Biointron is pleased to announce our participation in the Society for Immunotherapy of Cancer’s 41st Annual Meeting & Pre-Conference Programs, taking place November 4–8, 2026, at the Phoenix Convention Center in Phoenix, Arizona. 

SITC 2026 is a leading international meeting dedicated to advancing cancer immunotherapy through scientific exchange, clinical education, and cross-disciplinary collaboration. Hosted by the Society for Immunotherapy of Cancer, the meeting brings together researchers, clinicians, industry representatives, regulatory experts, and early-career scientists working to improve cancer patient outcomes through basic and applied immuno-oncology research. 

The 2026 program will highlight key developments across cancer immunology and immunotherapy, including T-cell recognition of human cancer, personalized cancer vaccines, tumor immune response and resistance, translational biomarkers, therapeutic combinations, and emerging strategies for improving clinical benefit. The meeting also includes abstract presentations, early-career scientist activities, exhibit programming, and networking opportunities designed to support interaction across academia, clinical research, and industry. 

Biointron looks forward to connect with everyone at booth #612. Join us with the cancer immunotherapy community in Phoenix, let’s engage in discussions that support continued progress in immuno-oncology and antibody-based therapeutic innovation! 

For more details about the event, please visit the Society for Immunotherapy of Cancer Annual Meeting 2026 website [https://www.sitcancer.org/2026/home] 

Time: November 4 – 8, 2026 

Location: Phoenix Convention Center | Phoenix, AZ 

Booth: #612